Geode Capital Management LLC trimmed its holdings in Shire PLC (NASDAQ:SHPG) by 14.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,279 shares of the biopharmaceutical company’s stock after selling 8,650 shares during the period. Geode Capital Management LLC’s holdings in Shire were worth $8,575,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in SHPG. United Services Automobile Association boosted its position in shares of Shire by 2.2% in the 3rd quarter. United Services Automobile Association now owns 16,267 shares of the biopharmaceutical company’s stock worth $2,949,000 after buying an additional 354 shares in the last quarter. Kepos Capital LP boosted its position in shares of Shire by 400.0% in the 3rd quarter. Kepos Capital LP now owns 425,000 shares of the biopharmaceutical company’s stock worth $77,040,000 after buying an additional 340,000 shares in the last quarter. Pacer Advisors Inc. boosted its position in shares of Shire by 13.4% in the 3rd quarter. Pacer Advisors Inc. now owns 6,452 shares of the biopharmaceutical company’s stock worth $1,170,000 after buying an additional 761 shares in the last quarter. APCM Wealth Management for Individuals purchased a new stake in shares of Shire in the 3rd quarter worth about $393,000. Finally, Alpine Global Management LLC purchased a new stake in shares of Shire in the 3rd quarter worth about $5,438,000. 20.23% of the stock is owned by institutional investors.
A number of research analysts have issued reports on the stock. BidaskClub upgraded shares of Shire from a “hold” rating to a “buy” rating in a report on Tuesday, December 25th. Cantor Fitzgerald set a $222.00 target price on shares of Shire and gave the company a “buy” rating in a report on Thursday, December 20th. Finally, William Blair lowered shares of Shire from an “outperform” rating to a “market perform” rating in a report on Thursday, December 20th. Seven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $201.60.
ILLEGAL ACTIVITY WARNING: “Shire PLC (SHPG) Stake Lessened by Geode Capital Management LLC” was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4296189/shire-plc-shpg-stake-lessened-by-geode-capital-management-llc.html.
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.
Read More: How to execute a trade ex-dividend strategy?
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.